Total Payments
$12,684
2024 Payments
$3,753
Companies
30
Transactions
558
Medicare Patients
792
Medicare Billing
$40,212
Payment Breakdown by Category
Food & Beverage$12,684 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,684 | 558 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,210 | 58 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,098 | 70 | $0 (2024) |
| Abbott Laboratories | $1,013 | 17 | $0 (2024) |
| PFIZER INC. | $913.86 | 40 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $913.25 | 38 | $0 (2024) |
| Amgen Inc. | $786.09 | 36 | $0 (2024) |
| Esperion Therapeutics, Inc. | $770.92 | 23 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $744.15 | 51 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $636.62 | 25 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $595.48 | 37 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,753 | 138 | PFIZER INC. ($429.58) |
| 2023 | $3,238 | 139 | Abbott Laboratories ($438.02) |
| 2022 | $2,897 | 151 | Janssen Pharmaceuticals, Inc ($435.28) |
| 2021 | $2,795 | 130 | Janssen Pharmaceuticals, Inc ($403.99) |
All Payment Transactions
558 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $8.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.66 | General |
| Category: Cardiovascular | ||||||
| 12/12/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Genetic Disease | ||||||
| 12/10/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Obesity | ||||||
| 12/02/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Cardiology | ||||||
| 11/29/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.20 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/12/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Cardiology | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | BIOTRONIK INC. | AMVIA EDGE (Device) | Food and Beverage | In-kind items and services | $54.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: Obesity | ||||||
| 10/22/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/17/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $5.04 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/16/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/09/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $8.59 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/07/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/03/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/01/2024 | BIOTRONIK INC. | Acticor 7 VR-T DX (Device), AMVIA EDGE | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 501 | 512 | $87,812 | $24,691 |
| 2022 | 3 | 107 | 107 | $17,958 | $5,532 |
| 2021 | 3 | 101 | 102 | $14,347 | $5,679 |
| 2020 | 3 | 83 | 87 | $7,668 | $4,310 |
Total Patients
792
Total Services
808
Medicare Billing
$40,212
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 164 | 173 | $42,339 | $13,584 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 109 | 110 | $17,848 | $6,189 | 34.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 22 | $7,813 | $2,408 | 30.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 77 | 77 | $5,852 | $1,031 | 17.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 97 | 98 | $7,848 | $854.43 | 10.9% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 32 | 32 | $6,112 | $624.34 | 10.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 57 | $12,483 | $4,295 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 25 | $3,700 | $1,034 | 27.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 25 | 25 | $1,775 | $202.94 | 11.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 42 | 42 | $8,058 | $3,414 | 42.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 37 | 37 | $4,776 | $2,068 | 43.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 22 | 23 | $1,513 | $198.00 | 13.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 29 | 31 | $3,844 | $2,168 | 56.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 38 | 40 | $3,120 | $1,900 | 60.9% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2020 | 16 | 16 | $704.00 | $241.96 | 34.4% |
About Whitney Putillion, PA-C
Whitney Putillion, PA-C is a Physician Assistant healthcare provider based in Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/25/2014. The National Provider Identifier (NPI) number assigned to this provider is 1134526825.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Whitney Putillion, PA-C has received a total of $12,684 in payments from pharmaceutical and medical device companies, with $3,753 received in 2024. These payments were reported across 558 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($12,684).
As a Medicare-enrolled provider, Putillion has provided services to 792 Medicare beneficiaries, totaling 808 services with total Medicare billing of $40,212. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Charleston, SC
- Active Since 11/25/2014
- Last Updated 05/22/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1134526825
Products in Payments
- JARDIANCE (Drug) $1,168
- XARELTO (Drug) $1,098
- LifeVest (Device) $913.25
- Repatha (Biological) $776.41
- ELIQUIS (Drug) $560.10
- VERQUVO (Drug) $513.50
- NEXLIZET (Drug) $436.21
- UPTRAVI (Drug) $422.63
- LEQVIO (Drug) $418.97
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $411.03
- FARXIGA (Drug) $350.06
- NEXLETOL (Drug) $334.71
- OPSUMIT (Drug) $321.52
- VYNDAQEL (Drug) $296.69
- CARDIOMEMS (Device) $277.26
- OPTIMIZER (Device) $259.93
- Arcalyst (Drug) $235.21
- FUROSCIX (Drug) $224.75
- CAMZYOS (Drug) $210.63
- AMPLATZER AMULET (Device) $207.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Charleston
Michael Overcash, Pa, PA
Physician Assistant — Payments: $168,472
Physician Assistant $168,472
Elizabeth Harding
Physician Assistant — Payments: $18,250
Physician Assistant $18,250
Corin Jaynes, Pa, PA
Physician Assistant — Payments: $11,995
Physician Assistant $11,995
Karen Byrd, Pa-C, PA-C
Physician Assistant — Payments: $11,725
Physician Assistant $11,725
John Richey, Pa-C, PA-C
Physician Assistant — Payments: $11,621
Physician Assistant $11,621
Amy Turner, Pa, PA
Physician Assistant — Payments: $10,800
Physician Assistant $10,800